title: Anorexia nervosa: towards a neurobiologically based therapy.
abstract: Eating disorders, i.e. anorexia and bulimia nervosa, are disorders of eating behavior and body weight regulation. Most likely because there are few, if any, effective treatments, eating disorders are considered to be chronic disorders interrupted only by intermittent periods of short-lived remission. The neurobiology of eating, most of which explores hypothalamic mechanisms, has had no influence on the treatment of eating disorders, with the exception of psychopharmacology. However, while most patients are treated with psychoactive drugs, there is no evidence that these are effective. This may be because pharmacological attempts so far have targeted the wrong symptoms. We review the symptomatology of anorexia and bulimia and the outcome of presently used interventions. Everybody agrees that outcome must improve and to attack this clinical problem, we suggest a neurobiologically plausible framework for how the disorders develop and how they are maintained and outline a method of treatment and its results.
authors: Section of Applied Neuroendocrinology, AB Mando, Center for Eating Disorders, Karolinska Institutet, Novum, S-141 57, Huddinge, Sweden. per.sodersten@neurotec.ki.se
authors: Per
authors: P
authors: Södersten
authors: Cecilia
authors: C
authors: Bergh
authors: Ahmed
authors: A
authors: Ammar
mesh_terms: D000818:Animals; D000856:Anorexia Nervosa / Q000188:drug therapy / Q000378:metabolism* / Q000628:therapy*; D000928:Antidepressive Agents / Q000627:therapeutic use; D006801:Humans; D007031:Hypothalamus / Q000187:drug effects / Q000378:metabolism; D011619:Psychotropic Drugs / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data
chemical_list: D000928:Antidepressive Agents; D011619:Psychotropic Drugs